Bill Overview
Title: Prostate Cancer Community Assistance, Research and Education Act of 2022
Description: This bill establishes a committee to develop, implement, and periodically revise a plan to coordinate federal activities and programs concerning prostate cancer, including those related to research, screening, diagnosis, and treatment. Committee members must include representatives from specified federal agencies, as well as researchers, clinicians, individuals living with prostate cancer (or their caregivers), and other stakeholders. In addition, at least half of the members must be physicians.
Sponsors: Rep. Murphy, Gregory [R-NC-3]
Target Audience
Population: Individuals affected by prostate cancer, including patients and at-risk populations
Estimated Size: 3200000
- Prostate cancer is one of the most common types of cancer affecting men, with a significant portion of the global male population being at risk.
- The legislation focuses on coordinating federal activities related to prostate cancer, impacting those affected directly by the disease and related healthcare professionals.
- The target population includes researchers, clinicians, patients living with prostate cancer, their families, caregivers, and potentially men at risk of developing prostate cancer globally.
Reasoning
- To cover a broad spectrum of the population, we will interview a mix of men diagnosed with prostate cancer, caregivers, researchers, and clinicians. We want to ensure a variety of perspectives, including those not directly benefiting from the program due to regional or demographic reasons.
- Considering the budget, the immediate impact in the first year is likely focused on planning and initial outreach, with more substantial effects seen in later years as programs develop and expand.
- Not everyone in the estimated 3.2 million target population will be affected initially due to logistical and reach limitations. Thus, varying levels of impact will be depicted.
Simulated Interviews
Retired teacher (Chicago, IL)
Age: 65 | Gender: male
Wellbeing Before Policy: 5
Duration of Impact: 10.0 years
Commonness: 6/20
Statement of Opinion:
- I hope the policy brings more consistency in treatment recommendations across the country.
- Funding more research might lead to new treatments that are less invasive.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 5 | 5 |
| Year 2 | 6 | 5 |
| Year 3 | 7 | 5 |
| Year 5 | 8 | 6 |
| Year 10 | 8 | 6 |
| Year 20 | 7 | 5 |
Software engineer (Dallas, TX)
Age: 50 | Gender: male
Wellbeing Before Policy: 6
Duration of Impact: 5.0 years
Commonness: 8/20
Statement of Opinion:
- I'm cautiously optimistic but want to see more personalized treatment options funded by the policy.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 6 | 6 |
| Year 2 | 7 | 6 |
| Year 3 | 7 | 6 |
| Year 5 | 7 | 6 |
| Year 10 | 7 | 6 |
| Year 20 | 6 | 5 |
Healthcare administrator (New York, NY)
Age: 40 | Gender: female
Wellbeing Before Policy: 6
Duration of Impact: 12.0 years
Commonness: 10/20
Statement of Opinion:
- The policy should address caregiver support and education.
- It seems promising that patient voices will be included.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 6 | 6 |
| Year 2 | 7 | 6 |
| Year 3 | 8 | 6 |
| Year 5 | 8 | 6 |
| Year 10 | 8 | 6 |
| Year 20 | 7 | 5 |
Prostate cancer researcher (Seattle, WA)
Age: 70 | Gender: male
Wellbeing Before Policy: 7
Duration of Impact: 20.0 years
Commonness: 4/20
Statement of Opinion:
- More funds for research will accelerate discovery and innovation.
- I hope it leads to more collaboration with federal support.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 8 | 7 |
| Year 2 | 8 | 7 |
| Year 3 | 9 | 7 |
| Year 5 | 9 | 7 |
| Year 10 | 9 | 7 |
| Year 20 | 9 | 6 |
Prostate cancer survivor (Orlando, FL)
Age: 55 | Gender: male
Wellbeing Before Policy: 8
Duration of Impact: 5.0 years
Commonness: 5/20
Statement of Opinion:
- Screening education should be a significant focus.
- I hope the policy helps to decrease disparities in care.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 8 | 8 |
| Year 2 | 8 | 8 |
| Year 3 | 9 | 8 |
| Year 5 | 9 | 8 |
| Year 10 | 8 | 8 |
| Year 20 | 7 | 7 |
Clinician specializing in oncology (Boston, MA)
Age: 60 | Gender: male
Wellbeing Before Policy: 7
Duration of Impact: 15.0 years
Commonness: 5/20
Statement of Opinion:
- Coordination among federal agencies can streamline guidelines and clinical trials.
- Policy should support telehealth initiatives.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 8 | 7 |
| Year 2 | 8 | 7 |
| Year 3 | 8 | 7 |
| Year 5 | 8 | 7 |
| Year 10 | 9 | 7 |
| Year 20 | 8 | 6 |
Primary care physician (Phoenix, AZ)
Age: 45 | Gender: male
Wellbeing Before Policy: 6
Duration of Impact: 5.0 years
Commonness: 12/20
Statement of Opinion:
- Expect enhanced access to resources for primary care providers.
- It’s crucial the policy includes well-rounded education.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 6 | 6 |
| Year 2 | 7 | 6 |
| Year 3 | 8 | 6 |
| Year 5 | 8 | 6 |
| Year 10 | 7 | 6 |
| Year 20 | 6 | 5 |
Retired mechanic (Detroit, MI)
Age: 75 | Gender: male
Wellbeing Before Policy: 6
Duration of Impact: 3.0 years
Commonness: 8/20
Statement of Opinion:
- Uncertain how the policy will affect someone who isn't diagnosed but is at risk.
- Preventive measures should be a priority.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 6 | 6 |
| Year 2 | 6 | 6 |
| Year 3 | 7 | 6 |
| Year 5 | 7 | 6 |
| Year 10 | 6 | 6 |
| Year 20 | 5 | 5 |
Retired government worker (Los Angeles, CA)
Age: 68 | Gender: male
Wellbeing Before Policy: 7
Duration of Impact: 10.0 years
Commonness: 7/20
Statement of Opinion:
- I believe this policy will help in advocacy efforts.
- There’s a need for more inclusive research funding.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 7 | 7 |
| Year 2 | 8 | 7 |
| Year 3 | 8 | 7 |
| Year 5 | 8 | 7 |
| Year 10 | 8 | 7 |
| Year 20 | 7 | 6 |
Graduate student in medical research (San Francisco, CA)
Age: 30 | Gender: male
Wellbeing Before Policy: 7
Duration of Impact: 15.0 years
Commonness: 15/20
Statement of Opinion:
- This policy might increase funding opportunities for new researchers.
- I hope for more mentoring programs through the committee.
Wellbeing Over Time (With vs Without Policy)
| Year | With Policy | Without Policy |
|---|---|---|
| Year 1 | 7 | 7 |
| Year 2 | 8 | 7 |
| Year 3 | 8 | 7 |
| Year 5 | 9 | 7 |
| Year 10 | 9 | 7 |
| Year 20 | 8 | 6 |
Cost Estimates
Year 1: $15000000 (Low: $10000000, High: $20000000)
Year 2: $15000000 (Low: $10000000, High: $20000000)
Year 3: $15000000 (Low: $10000000, High: $20000000)
Year 5: $15000000 (Low: $10000000, High: $20000000)
Year 10: $0 (Low: $0, High: $0)
Year 100: $0 (Low: $0, High: $0)
Key Considerations
- Costs primarily arise from the operational and administrative needs of the new committee.
- Long-term savings could be achieved through better coordination and improved health outcomes.
- The bill does not include direct funding for prostate cancer research, thus primarily influencing federal coordination rather than expanding research budgets.